Frontiers in Cellular and Infection Microbiology (2024)
Thabo Lapp, Paola Kammrath Betancor, Günther Schlunck, Claudia Auw-Hädrich, Philip Maier, Clemens Lange, Thomas Reinhard, Julian Wolf
Number of citations (crossref.org): Loading....
Purpose: Corneal infections are a leading cause of visual impairment and blindness
worldwide. Here we applied high-resolution transcriptomic profiling to assess the
general and pathogen-specific molecular and cellular mechanisms during human corneal infection.
Methods: Clinical diagnoses of herpes simplex virus (HSV) (n=5) and bacterial/fungal (n=5)
keratitis were confirmed by histology. Healthy corneas (n=7) and keratoconus (n=4) samples
served as controls. Formalin-fixed, paraffin-embedded (FFPE) human corneal specimens were
analyzed using the 3’ RNA sequencing method Massive Analysis of cDNA Ends (MACE RNA-seq).
The cellular host response was investigated using comprehensive bioinformatic deconvolution
(xCell and CYBERSORTx) analyses and by integration with published single cell RNA-seq
data of the human cornea.
Results: Our analysis identified 216 and 561 genes, that were specifically overexpressed
in viral or bacterial/fungal keratitis, respectively, and allowed to distinguish the two
etiologies. The virus-specific host response was driven by adaptive immunity and associated
molecular signaling pathways, whereas the bacterial/fungal-specific host response mainly
involved innate immunity signaling pathways and cell types. We identified several genes and
pathways involved in the host response to infectious keratitis, including CXCL9, CXCR3, and
MMP9 for viral, and S100A8/A9, MMP9, and the IL17 pathway for bacterial/fungal keratitis.
Conclusions: High-resolution molecular profiling provides new insights into the human corneal
host response to viral and bacterial/fungal infection. Pathogen-specific molecular profiles may
provide the foundation for novel diagnostic biomarker and therapeutic approaches that target
inflammation-induced damage to corneal host cells with the goal to improve the outcome of infectious keratitis.